Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata

被引：0
|
作者：
Dai, Z. [1 ]
Loesch, E. [1 ]
Chen, J. C. [1 ]
Wang, E. [1 ]
Lee, E. [1 ]
Christiano, A. [1 ]
机构：
[1] Columbia Univ, Dermatol, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2019年 / 139卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
695
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [31] Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor
    G. N. Zyuz’kov
    V. V. Zhdanov
    E. V. Udut
    L. A. Miroshnichenko
    E. V. Simanina
    T. Yu. Polyakova
    L. A. Stavrova
    V. V. Udut
    M. Yu. Minakova
    A. M. Dygai
    Bulletin of Experimental Biology and Medicine, 2016, 162 : 240 - 243
  • [32] Delineation of the regions of interleukin-2 (IL-2) receptor β chain important for association of Jak1 and Jak3 -: Jak1-independent functional recruitment of Jak3 to IL-2Rβ
    Zhu, MH
    Berry, JA
    Russell, SM
    Leonard, WJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) : 10719 - 10725
  • [33] 3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models
    Soth, Michael
    Hermann, Johannes C.
    Yee, Calvin
    Alam, Muzaffar
    Barnett, Jim W.
    Berry, Pamela
    Browner, Michelle F.
    Frank, Karl
    Frauchiger, Sandra
    Harris, Seth
    He, Yang
    Hekmat-Nejad, Mohammad
    Hendricks, Than
    Henningsen, Robert
    Hilgenkamp, Ramona
    Ho, Hoangdung
    Hoffman, Ann
    Hsu, Pei-Yuan
    Hu, Dong-Qing
    Itano, Andrea
    Jaime-Figueroa, Saul
    Jahangir, Alam
    Jin, Sue
    Kuglstatter, Andreas
    Kutach, Alan K.
    Liao, Cheng
    Lynch, Stephen
    Menke, John
    Niu, Linghao
    Patel, Vaishali
    Railkar, Aruna
    Roy, Douglas
    Shao, Ada
    Shaw, David
    Steiner, Sandra
    Sun, Yongliang
    Tan, Seng-Lai
    Wang, Sandra
    Minh Diem Vu
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (01) : 345 - 356
  • [34] Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
    Montilla, Ana M.
    Gomez-Garcia, Francisco
    Gomez-Arias, Pedro J.
    Gay-Mimbrera, Jesus
    Hernandez-Parada, Jorge
    Isla-Tejera, Beatriz
    Ruano, Juan
    DERMATOLOGY AND THERAPY, 2019, 9 (04) : 655 - 683
  • [35] Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
    Ana M. Montilla
    Francisco Gómez-García
    Pedro J. Gómez-Arias
    Jesús Gay-Mimbrera
    Jorge Hernández-Parada
    Beatriz Isla-Tejera
    Juan Ruano
    Dermatology and Therapy, 2019, 9 : 655 - 683
  • [36] Activation of the Jak3 pathway and myeloid differentiation
    Mangan, JK
    Reddy, EP
    LEUKEMIA & LYMPHOMA, 2005, 46 (01) : 21 - 27
  • [37] Blocking JAK1/JAK2 While Sparing JAK3 Not Only Prevents GvHD but Also Promotes Damaged Tissue Repair
    Ashami, Kidist
    Kim, Sena
    Vij, Ravi
    Ritchey, Julie K.
    Santhanam, Srikanth
    Lim, Sora
    Peterson, Sarah
    Ciorba, Matthew
    DiPersio, John F.
    Choi, Jaebok
    BLOOD, 2019, 134
  • [38] Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation
    Liu, KD
    Gaffen, SL
    Goldsmith, MA
    Greene, WC
    CURRENT BIOLOGY, 1997, 7 (11) : 817 - 826
  • [39] JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
    Govaerts, Inge
    Jacobs, Kris
    Vandepoel, Roel
    Cools, Jan
    HEMASPHERE, 2019, 3 (06):
  • [40] Cross-specialty identification of the JAK1 inhibitor trial agent filgotinib as a potential therapy for alopecia areata
    Fagan, Nicole
    Doherty, Glen A.
    Meah, Nekma
    Sinclair, Rodney
    Wall, Dmitri
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (03) : 442 - 443
12345